In vitro Genome Engineering & Disease Modelling

To complement our established in vivo capabilities, and address an important capability gap for the research community, Phenomics Australia is actively expanding our range of in vitro engineering and disease modelling system to include cell-, organoid- and tissue-based models, as well as 3D bioprinting.


  • 3D bioprinting

  • CRISPR in cells

  • Organoids

  • Human iPSCs

  • Patient-derived lines

  • Cell and tissue cultures

  • High-throughput imaging and screening

  • Stem cell molecular data

  • Training, consultancy and technical support


Like our established in vivo capabilities, in vitro genome engineering and disease modelling involves the generation of tailored models which can possess targeted mutations of interest and which can replicate clinical findings. These models are an increasingly valuable tool for health discovery and the early trialling of prospective therapies. Models on offer can be genetically engineered using our established CRISPR technologies, and also spatially engineered using 3D bioprinting to replicate natural physiology.  


This platform enables highly complex co-culture interaction studies, including tumour and immune cells, host-pathogen interactions, angiogenesis and cell invasion. Using our Janus G3 robot and our Rastrum bioprinter, cells of interest can be embedded in customised hydrogels (bioinks) of varying composition and stiffness in both 96 and 384 well format. We can currently perform large and small scale compound screening coupled with sophisticated imaging in label-free and fluorescent settings. We have developed a customised analysis pipeline that can measure structure size and viability and importantly, can measure hundreds of unbiased cellular features to cluster structures into groups with like phenotypic signatures. This powerful method can rapidly transform the identification of a large ‘hit list’ into a focused sub-set. We have developed this pipeline for cell lines, PDX-derived patient cells or directly derived patient materials, allowing us to begin to make dissect cellular responses and make therapeutic predictions.

The CRISPR technology enables the production of a number of mutations not previously possible using conventional gene targeting.  We can generate knock-out, knock-in, point-mutated and tagged versions of your favourite gene in a wide variety of both human and mouse cell lines. we currently offer use of our proven cell lines (hESC, HEK293, MDA-MB-231, A549, MCF7, KPC, C26, mESC) and we are happy to consider others as projects require.

Further Information

Phenomics Australia provides a national centre of expertise and service provision to deploy a more comprehensive and sophisticated range of in vitro Genome Engineering and Disease Modelling capabilities to understand the functional consequences of DNA sequence variation in the human genome for health and disease while maintaining the expertise for in vivo disease modelling and genome engineering. To meet the high demand for adaptable and scalable disease-modelling platforms for improved diagnosis, Precision Medicine for genetic disorders, and therapeutic development by both academia and the biopharmaceutical industry, Phenomics Australia offers In Vitro services through a collaborative consortium of ten laboratories and facilities across Australia, operating at ANU (AG), Perkins (LW), Monash (HA, AC), MCRI (SH), Peter Mac (KS), UMelb (CW & AP), UQ (EW), and VCCRI (SD)

Phenomics Australia Feedback Form

Phenomics Australia (formerly the Australian Phenomics Network, APN) offers consolidated infrastructure and expertise supporting genomic medicine and biomedical research from discovery through into early clinical development and evaluation.

Phenomics Australia is a founding capability enabled by the National Collaborative Research Infrastructure Strategy (NCRIS). We would love to hear from you!

Please feel free to provide any ideas or general comments you might have so that we can further improve how Phenomics Australia can support you.

Phenomics Australia PHENOMENA News Contribution

Have you recently had a publication accepted? Do you want to tell us about a grant you have received? Or maybe you have just been recently in the news? You can complete this form to tell us about your latest research developments.

Information provided will be used to inform press releases, website stories, social media content and more. This form is being used to capture everything that is happening at Phenomics Australia, which can then be used as part of our outreach and communications.

Once you have completed the form, the Communications and Outreach Coordinator will then be in contact with you.


Make an Enquiry

_Get in touch to discuss how we can help with your research.